Nat. Rev. Endocrinol. doi: /nrendo

Slides:



Advertisements
Similar presentations
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Advertisements

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Childhood craniopharyngioma
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 2 Regions of Africa exposed to undernutrition
Figure 3 Life expectancy at birth in all countries included
Figure 1 Male infertility and assisted reproduction globally
Figure 2 Pathophysiology of hyperglycaemia in T2DM
with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 4 Amino acid structure of short-acting and long-acting insulins
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Physiological changes in the renal system in pregnancy
Figure 1 Mendelian randomization study
Figure 1 Adverse effects in women treated with HRT
Figure 1 Monogenic forms of diabetes mellitus
Figure 5 MRI of childhood craniopharyngioma
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 The Beckwith–Wiedemann spectrum
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Intensity-based loading options to increase bone strength
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Osteosarcoma epidemiology
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Challenges and opportunities of using omics in EDC research
Figure 1 Oestrogen biosynthesis and production sites in the body
Figure 3 Satiety, bacterial growth and satiety hormone release
Figure 3 Possible modalities for reconciliation of patient's and physician's report of symptomatic treatment-associated toxicities Figure 3 | Possible.
Figure 2 Pharmacokinetic action profiles of rapid-acting insulins
Figure 4 Tracheal endoscopy in two patients
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Serum levels of TSH and free T4 in a large series
Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 BMPs in brown and beige adipogenesis and function
Figure 3 Stroke-related deaths and DALYs by country development status
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Exosomes mediate the systemic benefits of endurance exercise
Figure 3 Pharmacodynamic action profiles of long-acting insulins
Nat. Rev. Endocrinol. doi: /nrendo
Figure 6 Joint morphogenesis
Fertility and Sterility  Volume 98, Issue 5, Pages (November 2012)
Figure 11-1.
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Oxidative phosphorylation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure Overview.
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Timeline of pancreatic islet transplantation
Figure 1 Exercise enhances insulin sensitivity
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Global iodine status and mandatory salt iodization
Increasing prevalence of multidrug resistance among P
Nat. Rev. Endocrinol. doi: /nrendo
Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.55 Figure 2 Temporal changes in the consumption of mild analgesics during pregnancy Figure 2 | Temporal changes in the consumption of mild analgesics during pregnancy. Percentage of women reporting analgesic use during pregnancy either per trimester or any time during pregnancy. Each point corresponds to percentages collected from references in Supplementary information S1 (table). Kristensen, D. M. et al. (2016) Analgesic use — prevalence, biomonitoring and endocrine and reproductive effects Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.55